This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyoto University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Isao Ito: Innovator in Alveolar Epithelial Progenitor Cell Manufacturing
Introduction
Isao Ito is a notable inventor based in Japan, recognized for his contributions to the field of stem cell research. His work focuses on developing methods to manufacture alveolar epithelial progenitor cells from pluripotent stem cells. This innovative approach has significant implications for regenerative medicine and lung disease treatment.
Latest Patents
Isao Ito holds a patent titled "Method For Inducing Alveolar Epithelial Progenitor Cells." The purpose of this invention is to provide a stable method for producing alveolar epithelium progenitor cells. The method involves several key processes: first, culturing pluripotent stem cells in a culture solution containing activin A and GSK3ß inhibitor; second, culturing the cells in a solution with BMP inhibitor and TGFß inhibitor; and third, culturing the cells in a solution containing BMP4, retinoic acid, and GSK3ß inhibitor. Although he has 1 patents, his research is pivotal in advancing the understanding of stem cell differentiation.
Career Highlights
Throughout his career, Isao Ito has made significant strides in the field of stem cell research. His innovative methods have opened new avenues for the treatment of various lung conditions. His dedication to research and development has positioned him as a key figure in the scientific community.
Collaborations
Isao Ito has collaborated with esteemed colleagues, including Kenji Osafune and Shimpei Gotoh. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the field of regenerative medicine.
Conclusion
Isao Ito's work in developing methods for inducing alveolar epithelial progenitor cells represents a significant advancement in stem cell research. His innovative approaches have the potential to transform treatments for lung diseases and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
